Table 2.
Clinical information of patients in recurrence group
Prognostic indicators | No. of patients (n = 13) |
---|---|
Gleason score | |
6 | 0 |
7 | 4 |
8 | 2 |
9 | 4 |
10 | 3 |
T staging | |
T2b | 1 |
T2c | 2 |
T3a | 4 |
T3b | 3 |
T4 | 3 |
Pre-treatment prostate-specific antigen (ng ml−1) | |
≤10 | 1 |
10–20 | 2 |
>20 | 10 |